Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023
May 04 2023 - 7:30AM
Business Wire
Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital
therapeutics (PDT) company developing a clinically validated,
software-based novel form of cognitive behavioral therapy to
address the root causes of cardiometabolic diseases, today
announced it will release its first quarter 2023 financial results
before the market opens on Thursday, May 11, 2023. Management will
host a conference call and webcast to provide a business update at
8:30 a.m. ET / 5:30 a.m. PT on Thursday, May 11, 2023.
To access the conference call, please register at:
https://register.vevent.com/register/BI5d9690c447df48b2b930b971560acd4f.
Upon registering, each participant will be provided with call
details and access codes. All participants are encouraged to join
10 minutes prior to the start time. The live webcast may be
accessed by visiting the event link at:
https://edge.media-server.com/mmc/p/khcj9g2y. Following the
webcast, a replay of the webcast may be accessed from the
Presentations & Events page in the Investors section of the
Better Therapeutics corporate website at:
https://investors.bettertx.com.
About Better Therapeutics
Better Therapeutics is a prescription digital therapeutics
company developing a novel form of cognitive behavioral therapy to
address the root causes of cardiometabolic diseases. The company
has developed a proprietary platform for the development of
FDA-regulated, software-based solutions for type 2 diabetes, heart
disease and other conditions. The CBT delivered by Better
Therapeutics’ PDT is designed to enable changes in neural pathways
of the brain so lasting changes in behavior become possible.
Addressing the underlying causes of these diseases has the
potential to dramatically improve patient health while lowering
healthcare costs. Better Therapeutics’ clinically validated mobile
applications, if authorized for marketing, are intended to be
prescribed by physicians and reimbursed like traditional
medicines.
For more information visit: bettertx.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230504005506/en/
Investor Relations: Mark Heinen IR@bettertx.com
Media Enquiries: Emma Williams
emma.williams@bettertx.com
Better Therapeutics (NASDAQ:BTTX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Better Therapeutics (NASDAQ:BTTX)
Historical Stock Chart
From Jul 2023 to Jul 2024